148.12
price up icon4.38%   6.22
after-market アフターアワーズ: 147.47 -0.65 -0.44%
loading
前日終値:
$141.90
開ける:
$142.47
24時間の取引高:
1.21M
Relative Volume:
0.82
時価総額:
$10.27B
収益:
$2.90B
当期純損益:
$302.80M
株価収益率:
34.47
EPS:
4.2965
ネットキャッシュフロー:
$387.80M
1週間 パフォーマンス:
+6.74%
1か月 パフォーマンス:
+6.27%
6か月 パフォーマンス:
-23.50%
1年 パフォーマンス:
-55.01%
1日の値動き範囲:
Value
$142.47
$148.35
1週間の範囲:
Value
$139.46
$148.35
52週間の値動き範囲:
Value
$126.40
$354.88

Insulet Corp Stock (PODD) Company Profile

Name
名前
Insulet Corp
Name
セクター
Healthcare (1051)
Name
電話
978-600-7000
Name
住所
100 NAGOG PARK, ACTON, MA
Name
職員
5,400
Name
Twitter
@insulet_uk
Name
次回の収益日
2026-11-04
Name
最新のSEC提出書
Name
PODD's Discussions on Twitter

Compare PODD vs ABT, MDT, SYK, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PODD icon
PODD
Insulet Corp
148.12 10.27B 2.90B 302.80M 387.80M 4.2965
ABT icon
ABT
Abbott Laboratories
102.51 177.38B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
96.59 123.55B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
307.08 117.79B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
46.01 66.68B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
90.09 51.93B 6.30B 1.07B 1.09B 1.8406

Insulet Corp Stock (PODD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-10-07 開始されました Barclays Equal Weight
2026-08-06 ダウングレード BTIG Research Buy → Neutral
2026-08-06 ダウングレード JP Morgan Overweight → Neutral
2026-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2026-08-06 ダウングレード Truist Buy → Hold
2026-08-06 ダウングレード Wells Fargo Overweight → Equal Weight
2026-08-05 ダウングレード Oppenheimer Outperform → Perform
2026-07-28 再開されました UBS Neutral
2026-06-23 開始されました Deutsche Bank Buy
2026-05-20 再開されました William Blair Outperform
2026-04-24 ダウングレード Rothschild & Co Redburn Buy → Neutral
2026-04-07 ダウングレード Citigroup Buy → Neutral
2026-01-27 再開されました TD Cowen Hold
2026-01-12 ダウングレード Barclays Overweight → Equal Weight
2025-12-16 開始されました Evercore ISI Outperform
2025-11-19 アップグレード UBS Neutral → Buy
2025-10-21 再開されました Stifel Buy
2025-09-08 再開されました Oppenheimer Outperform
2025-06-16 開始されました Truist Buy
2025-05-30 開始されました Goldman Buy
2025-05-13 アップグレード Wolfe Research Peer Perform → Outperform
2025-04-29 ダウングレード Wolfe Research Outperform → Peer Perform
2025-03-06 開始されました RBC Capital Mkts Outperform
2024-11-06 開始されました Bernstein Outperform
2024-05-30 開始されました Redburn Atlantic Buy
2024-05-07 アップグレード Wolfe Research Peer Perform → Outperform
2023-12-21 アップグレード Robert W. Baird Neutral → Outperform
2023-12-04 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-10-02 アップグレード Jefferies Hold → Buy
2023-08-21 アップグレード Citigroup Neutral → Buy
2023-08-21 ダウングレード Robert W. Baird Outperform → Neutral
2023-05-30 再開されました Morgan Stanley Equal-Weight
2023-01-26 開始されました Wolfe Research Peer Perform
2022-11-04 アップグレード Piper Sandler Neutral → Overweight
2022-10-18 開始されました Barclays Equal Weight
2022-10-12 開始されました Jefferies Hold
2022-07-11 ダウングレード Citigroup Buy → Neutral
2022-03-02 再開されました BofA Securities Buy
2022-02-03 アップグレード BTIG Research Neutral → Buy
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-31 アップグレード Oppenheimer Perform → Outperform
2021-07-21 再開されました Cowen Outperform
2021-05-25 開始されました Barclays Overweight
2021-04-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-03-19 アップグレード Canaccord Genuity Hold → Buy
2021-01-29 ダウングレード Piper Sandler Overweight → Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-07-28 開始されました Wells Fargo Overweight
2020-04-24 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-04-03 開始されました BofA/Merrill Neutral
2020-03-31 ダウングレード Berenberg Buy → Hold
2020-03-05 開始されました Citigroup Buy
2019-12-10 開始されました CFRA Sell
2019-10-23 開始されました Stifel Hold
2019-10-18 ダウングレード Canaccord Genuity Buy → Hold
2019-10-14 ダウングレード BTIG Research Buy → Neutral
2019-10-04 ダウングレード UBS Buy → Neutral
2019-10-03 ダウングレード Guggenheim Buy → Neutral
2019-08-06 アップグレード JP Morgan Neutral → Overweight
2019-06-10 ダウングレード Northland Capital Outperform → Market Perform
2019-05-06 アップグレード BTIG Research Neutral → Buy
2018-04-20 開始されました Berenberg Buy
2018-02-22 繰り返されました Barclays Overweight
2018-01-08 アップグレード Raymond James Mkt Perform → Outperform
2017-11-03 アップグレード Canaccord Genuity Hold → Buy
2017-09-15 開始されました Barclays Overweight
すべてを表示

Insulet Corp (PODD) 最新ニュース

pulisher
Oct 21, 2026

Insulet Corp (GOV.DU) stock major holders - Yahoo Finance Australia

Oct 21, 2026
pulisher
Oct 21, 2026

Global Digital Health and Remote Patient Monitoring Strategic Market Report, 2026-2031 | 20.2% CAGR to $80.8 Billion as Connected Care and Wearables Scale - GlobeNewswire Inc.

Oct 21, 2026
pulisher
Oct 20, 2026

Bronstein, Gewirtz & Grossman (PODD) Investigation: Bronstein, Ge - The National Law Review

Oct 20, 2026
pulisher
Oct 20, 2026

DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study - Zacks Investment Research

Oct 20, 2026
pulisher
Oct 19, 2026

Full Fed. Circ. Won't Revive Insulet's $59M Trade Secrets Win - Law360

Oct 19, 2026
pulisher
Oct 17, 2026

MONDAY INVESTOR DEADLINE: Insulet Corporation (PODD) Investors wi - The National Law Review

Oct 17, 2026
pulisher
Oct 16, 2026

PODD Investors Have Opportunity to Lead Insulet Corporation Class - The National Law Review

Oct 16, 2026
pulisher
Oct 16, 2026

Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 16, 2026
pulisher
Oct 16, 2026

Insulet Ordered to Defend Retirement Plan’s Target-Date Funds - Bloomberg Law News

Oct 16, 2026
pulisher
Oct 16, 2026

Here's Why Insulet (PODD) is a Strong Growth Stock - Zacks Investment Research

Oct 16, 2026
pulisher
Oct 14, 2026

Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 14, 2026
pulisher
Oct 13, 2026

Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch

Oct 13, 2026
pulisher
Oct 13, 2026

Insulet Launches Omnipod Discover Diabetes Data Platform Nationwide - Medical Product Outsourcing

Oct 13, 2026
pulisher
Oct 13, 2026

Insulet’s Omnipod Discover platform sees full market release in US - Fierce Biotech

Oct 13, 2026
pulisher
Oct 12, 2026

A Look at Insulet Corp (PODD) After 3.4% Gain -- GF Value $398.3 - GuruFocus

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Stock Gains as Traders Weigh Bullish Analyst Stance Against a Depressed Share Price - Quiver Quantitative

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 12, 2026
pulisher
Oct 12, 2026

PODD Maintains Buy Rating -- Price Target Lowered to $190 by Jef - GuruFocus

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Launches Omnipod Discover Platform Across US - www.marketscreener.com

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Launches Omnipod Discover Platform Across US - Yahoo Finance

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet launches Omnipod Discover data platform in U.S. By Investing.com - Investing.com South Africa

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet launches Omnipod Discover data platform in U.S. - Investing.com

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet launches Omnipod Discover data platform in the U.S. - StreetInsider

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Announces Omnipod Discover Now Available in U.S. - Business Wire

Oct 12, 2026
pulisher
Oct 12, 2026

Jefferies cuts Insulet stock price target on competition concerns - Investing.com

Oct 12, 2026
pulisher
Oct 12, 2026

Insulet Corporation (PODD) PT Lowered to $190 at Jefferies - StreetInsider

Oct 12, 2026
pulisher
Oct 12, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Bronstein, Gewirtz & Grossman (PODD) Investors to Inquire about Securities Investigation - ACCESS Newswire

Oct 12, 2026
pulisher
Oct 11, 2026

Form 4 Insulet Corporation For: 11 October By Investing.com - Investing.com South Africa

Oct 11, 2026
pulisher
Oct 09, 2026

Leerink Partners Adjusts Insulet Price Target to $143 From $145 - marketscreener.com

Oct 09, 2026
pulisher
Oct 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Oct 08, 2026
pulisher
Oct 08, 2026

Insulet Q2FY26 Results: Revenue up 23% YoY, adjusted EPS rises 41.5% - scanx.trade

Oct 08, 2026
pulisher
Oct 08, 2026

Insulet Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga

Oct 08, 2026
pulisher
Oct 08, 2026

Insulet Corp Lobbying Profile, 2018 - OpenSecrets

Oct 08, 2026
pulisher
Oct 07, 2026

Insulet stock gets a Barclays Hold rating with USD 150 target - AD HOC NEWS

Oct 07, 2026
pulisher
Oct 07, 2026

Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance

Oct 07, 2026
pulisher
Oct 06, 2026

Insulet Corp Share PricePODD, RNS News, Articles, Quotes, & Charts (NASDAQ:PODD) - Proactive financial news

Oct 06, 2026
pulisher
Oct 06, 2026

Barclays Starts Insulet Corporation (PODD) at Equalweight - StreetInsider

Oct 06, 2026
pulisher
Oct 06, 2026

Barclays Starts Insulet Corporation (PODD) at Equalweight - StreetInsider

Oct 06, 2026
pulisher
Oct 06, 2026

Form 4 Insulet Corporation For: 6 October By Investing.com - Investing.com India

Oct 06, 2026
pulisher
Oct 06, 2026

Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement - Lelezard

Oct 06, 2026
pulisher
Oct 06, 2026

Form 4 Insulet Corporation For: 6 October By Investing.com - Investing.com South Africa

Oct 06, 2026
pulisher
Oct 05, 2026

Insulet (PODD) CFO Flavia Pease has 1,882 shares withheld for vesting taxes at $130.79 each. - Stock Titan

Oct 05, 2026
pulisher
Oct 05, 2026

Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 05, 2026
pulisher
Oct 03, 2026

PODD Should I Buy - Intellectia AI

Oct 03, 2026
pulisher
Oct 03, 2026

Form 4 Insulet Corporation For: 2 October By Investing.com - Investing.com South Africa

Oct 03, 2026
pulisher
Oct 02, 2026

A director receives 141 stock units instead of cash compensation at Insulet (PODD). - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

Stock units replace cash pay for Insulet (PODD) director Huffines, who received 178 units. - Stock Titan

Oct 02, 2026
pulisher
Oct 01, 2026

Important Notice to Long-Term Shareholders of Beta Bionics, - GlobeNewswire

Oct 01, 2026
pulisher
Oct 01, 2026

Press Release: Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026 - Moomoo

Oct 01, 2026
pulisher
Oct 01, 2026

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026 - Business Wire

Oct 01, 2026

Insulet Corp (PODD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Insulet Corp (PODD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
WEATHERMAN ELIZABETH H
Director
Jun 03 '26
Buy
144.20
3,450
497,490
10,352
BORIO LUCIANA
Director
Jun 03 '26
Proposed Sale
143.26
418
59,885
0
STONESIFER TIMOTHY C.
Director
Jun 03 '26
Buy
143.51
2,790
400,393
9,041
BORIO LUCIANA
Director
Jun 03 '26
Sale
143.27
418
59,887
4,329
MINOGUE MICHAEL R
Director
Feb 25 '26
Buy
246.23
2,030
499,847
17,483
McEvoy Ashley
President and CEO
Feb 20 '26
Buy
239.35
4,300
1,029,205
13,916
Frederick Wayne A.I.
Director
Dec 15 '25
Proposed Sale
293.09
1,851
542,500
0
Frederick Wayne A.I.
Director
Dec 15 '25
Sale
293.09
1,851
542,510
2,158
STONESIFER TIMOTHY C.
Director
Dec 05 '25
Buy
311.73
962
299,884
4,591
Manea Dan
Former Officer
Nov 26 '25
Proposed Sale
326.64
4,475
1,461,716
0
$176.69
price down icon 0.09%
$364.15
price down icon 0.25%
BIO BIO
$363.50
price up icon 0.83%
$81.66
price up icon 3.79%
TXG TXG
$69.75
price down icon 7.73%
$57.31
price down icon 3.04%
大文字化:     |  ボリューム (24 時間):